CA Stock MarketDetailed Quotes

Eastwood Bio-Medical Canada Inc (EBM)

Watchlist
  • 0.750
  • 0.0000.00%
15min DelayMarket Closed May 1 16:00 ET
51.66MMarket Cap-75.00P/E (TTM)

Eastwood Bio-Medical Canada Inc (EBM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2026
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-121.94%-900
147.89%7.29K
-174.77%-21.63K
167.60%11.88K
12.74%12.93K
432.41%4.1K
9.89%-15.22K
-399.89%-7.87K
-521.68%-17.58K
288.22%11.47K
Net income from continuing operations
49.68%-20.73K
27.00%-332.77K
50.71%-76.87K
49.98%-57.81K
-20.59%-156.9K
24.06%-41.19K
16.60%-455.87K
15.36%-155.94K
1.47%-115.58K
26.00%-130.11K
Operating gains losses
----
----
----
----
----
----
-390.48%-244
----
----
----
Depreciation and amortization
-76.75%10.45K
-58.19%44.96K
--0
--0
--0
68.81%44.96K
-0.29%107.54K
2.50%27.64K
-1.21%26.64K
-1.22%26.64K
Other non cashItems
----
-28.90%15.02K
----
----
----
-25.10%7.78K
410.84%21.12K
67.04%-7.8K
0.00%9.27K
0.00%9.27K
Change In working capital
2,766.06%9.37K
-6.45%292.09K
-59.34%52.24K
12.24%69.7K
60.70%169.83K
-97.95%327
-25.24%312.24K
-29.98%128.48K
-20.64%62.1K
-20.85%105.68K
-Change in receivables
-237.13%-46.67K
199.45%28.26K
-16.83%-6.35K
700.00%21.92K
-654.77%-21.34K
246.82%34.03K
-23,016.94%-28.42K
-152.56%-5.43K
76.51%-3.65K
143.81%3.85K
-Change in prepaid assets
---245
--0
--0
--0
--0
--0
42.40%48.94K
-3.18%49.73K
114.50%145
98.71%-200
-Change in payables and accrued expense
352.29%55.06K
-22.46%269.34K
-32.78%64.83K
1.15%45.07K
72.71%181.28K
-121.52%-21.82K
738.56%347.38K
141.84%96.44K
-55.42%44.55K
-32.60%104.96K
-Change in other working capital
110.32%1.23K
90.10%-5.51K
49.11%-6.24K
-87.12%2.71K
437.78%9.9K
80.69%-11.88K
-116.29%-55.66K
-103.48%-12.26K
509.57%21.05K
-241.75%-2.93K
Cash from discontinued investing activities
Operating cash flow
-121.94%-900
226.85%19.3K
-22.13%-9.61K
167.60%11.88K
12.74%12.93K
432.41%4.1K
9.89%-15.22K
-399.89%-7.87K
-521.68%-17.58K
288.22%11.47K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-173.42%-3.34K
95.43%-211
202.19%6.67K
-139.33%-8.81K
71.79%-2.63K
140.68%4.55K
-2.58%-4.62K
-58.75%-6.53K
389.97%22.41K
-137.40%-9.3K
Net issuance payments of debt
-173.42%-3.34K
95.43%-211
202.19%6.67K
-139.33%-8.81K
71.79%-2.63K
140.68%4.55K
-2.58%-4.62K
-58.75%-6.53K
389.97%22.41K
-137.40%-9.3K
Cash from discontinued financing activities
Financing cash flow
-173.42%-3.34K
95.43%-211
202.19%6.67K
-139.33%-8.81K
71.79%-2.63K
140.68%4.55K
-2.58%-4.62K
-58.75%-6.53K
389.97%22.41K
-137.40%-9.3K
Net cash flow
Beginning cash position
--17.7K
-107.52%-1.39K
69.28%22.03K
131.50%18.96K
43.16%8.62K
--0
-53.69%18.45K
-34.72%13.02K
-73.14%8.19K
-48.55%6.02K
Current changes in cash
-149.19%-4.24K
196.25%19.09K
79.59%-2.94K
-36.33%3.07K
377.19%10.34K
169.41%8.62K
7.27%-19.84K
-867.29%-14.4K
145.71%4.83K
-88.47%2.17K
End cash Position
56.10%13.46K
1,375.50%17.7K
1,375.50%17.7K
69.28%22.03K
131.50%18.96K
43.16%8.62K
-107.52%-1.39K
-107.52%-1.39K
-34.72%13.02K
-73.14%8.19K
Free cash from
-121.94%-900
226.85%19.3K
-22.13%-9.61K
167.60%11.88K
12.74%12.93K
432.41%4.1K
9.89%-15.22K
-399.89%-7.87K
-521.68%-17.58K
288.22%11.47K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jan 31, 2026(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -121.94%-900147.89%7.29K-174.77%-21.63K167.60%11.88K12.74%12.93K432.41%4.1K9.89%-15.22K-399.89%-7.87K-521.68%-17.58K288.22%11.47K
Net income from continuing operations 49.68%-20.73K27.00%-332.77K50.71%-76.87K49.98%-57.81K-20.59%-156.9K24.06%-41.19K16.60%-455.87K15.36%-155.94K1.47%-115.58K26.00%-130.11K
Operating gains losses -------------------------390.48%-244------------
Depreciation and amortization -76.75%10.45K-58.19%44.96K--0--0--068.81%44.96K-0.29%107.54K2.50%27.64K-1.21%26.64K-1.22%26.64K
Other non cashItems -----28.90%15.02K-------------25.10%7.78K410.84%21.12K67.04%-7.8K0.00%9.27K0.00%9.27K
Change In working capital 2,766.06%9.37K-6.45%292.09K-59.34%52.24K12.24%69.7K60.70%169.83K-97.95%327-25.24%312.24K-29.98%128.48K-20.64%62.1K-20.85%105.68K
-Change in receivables -237.13%-46.67K199.45%28.26K-16.83%-6.35K700.00%21.92K-654.77%-21.34K246.82%34.03K-23,016.94%-28.42K-152.56%-5.43K76.51%-3.65K143.81%3.85K
-Change in prepaid assets ---245--0--0--0--0--042.40%48.94K-3.18%49.73K114.50%14598.71%-200
-Change in payables and accrued expense 352.29%55.06K-22.46%269.34K-32.78%64.83K1.15%45.07K72.71%181.28K-121.52%-21.82K738.56%347.38K141.84%96.44K-55.42%44.55K-32.60%104.96K
-Change in other working capital 110.32%1.23K90.10%-5.51K49.11%-6.24K-87.12%2.71K437.78%9.9K80.69%-11.88K-116.29%-55.66K-103.48%-12.26K509.57%21.05K-241.75%-2.93K
Cash from discontinued investing activities
Operating cash flow -121.94%-900226.85%19.3K-22.13%-9.61K167.60%11.88K12.74%12.93K432.41%4.1K9.89%-15.22K-399.89%-7.87K-521.68%-17.58K288.22%11.47K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -173.42%-3.34K95.43%-211202.19%6.67K-139.33%-8.81K71.79%-2.63K140.68%4.55K-2.58%-4.62K-58.75%-6.53K389.97%22.41K-137.40%-9.3K
Net issuance payments of debt -173.42%-3.34K95.43%-211202.19%6.67K-139.33%-8.81K71.79%-2.63K140.68%4.55K-2.58%-4.62K-58.75%-6.53K389.97%22.41K-137.40%-9.3K
Cash from discontinued financing activities
Financing cash flow -173.42%-3.34K95.43%-211202.19%6.67K-139.33%-8.81K71.79%-2.63K140.68%4.55K-2.58%-4.62K-58.75%-6.53K389.97%22.41K-137.40%-9.3K
Net cash flow
Beginning cash position --17.7K-107.52%-1.39K69.28%22.03K131.50%18.96K43.16%8.62K--0-53.69%18.45K-34.72%13.02K-73.14%8.19K-48.55%6.02K
Current changes in cash -149.19%-4.24K196.25%19.09K79.59%-2.94K-36.33%3.07K377.19%10.34K169.41%8.62K7.27%-19.84K-867.29%-14.4K145.71%4.83K-88.47%2.17K
End cash Position 56.10%13.46K1,375.50%17.7K1,375.50%17.7K69.28%22.03K131.50%18.96K43.16%8.62K-107.52%-1.39K-107.52%-1.39K-34.72%13.02K-73.14%8.19K
Free cash from -121.94%-900226.85%19.3K-22.13%-9.61K167.60%11.88K12.74%12.93K432.41%4.1K9.89%-15.22K-399.89%-7.87K-521.68%-17.58K288.22%11.47K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More